 | • レポートコード：QYR2104Z6083 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、女性健康のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（閉経後骨粗鬆症、子宮内膜症、多嚢胞性卵巣症候群、不妊症、閉経、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・女性健康の市場動向 ・企業の競争状況、市場シェア ・女性健康の種類別市場規模（閉経後骨粗鬆症、子宮内膜症、多嚢胞性卵巣症候群、不妊症、閉経、その他） ・女性健康の用途別市場規模（病院、診療所、その他） ・女性健康の北米市場規模2016-2027（アメリカ、カナダ） ・女性健康のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・女性健康のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・女性健康の中南米市場規模2016-2027（メキシコ、ブラジル） ・女性健康の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Bayer、Merck、Pfizer、Teva Pharmaceutical、Agile Therapeutics、Amgen、Apothecus Pharmaceutical、AstraZeneca、Blairex Laboratories、Bristol-Myers Squibb、Ferring） ・結論 |
Women are more prone to certain diseases, such as osteoporosis, osteoarthritis, anemia, menstruation-related disorders, depression, and obesity. Hence, increase in incidence of these conditions is likely to boost the market in the coming years.
Government and various private organizations are working toward improving women’s health across the world, and this is likely to drive growth in the coming years. Reimbursement coverage provided to women is also a key factor driving the market in developed countries. For instance, various coverage plans in the U.S. provide preventive services for women without charging any copayment. These include screening for anemia, hepatitis B, & breast cancer on a routine basis, folic acid supplements for women who are likely to be pregnant, and contraceptive methods, among others.
Market Analysis and Insights: Global Womens Health Market
The global Womens Health market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Womens Health market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Womens Health market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Womens Health market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Womens Health market.
Global Womens Health Scope and Market Size
Womens Health market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Womens Health market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Postmenopausal Osteoporosis
Endometriosis
Polycystic Ovary Syndrome
Infertility
Menopause
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Bayer
Merck
Pfizer
Teva Pharmaceutical
Agile Therapeutics
Amgen
Apothecus Pharmaceutical
AstraZeneca
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Womens Health Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Postmenopausal Osteoporosis
1.2.3 Endometriosis
1.2.4 Polycystic Ovary Syndrome
1.2.5 Infertility
1.2.6 Menopause
1.2.7 Others
1.3 Market by Application
1.3.1 Global Womens Health Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Womens Health Market Perspective (2016-2027)
2.2 Womens Health Growth Trends by Regions
2.2.1 Womens Health Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Womens Health Historic Market Share by Regions (2016-2021)
2.2.3 Womens Health Forecasted Market Size by Regions (2022-2027)
2.3 Womens Health Industry Dynamic
2.3.1 Womens Health Market Trends
2.3.2 Womens Health Market Drivers
2.3.3 Womens Health Market Challenges
2.3.4 Womens Health Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Womens Health Players by Revenue
3.1.1 Global Top Womens Health Players by Revenue (2016-2021)
3.1.2 Global Womens Health Revenue Market Share by Players (2016-2021)
3.2 Global Womens Health Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Womens Health Revenue
3.4 Global Womens Health Market Concentration Ratio
3.4.1 Global Womens Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Womens Health Revenue in 2020
3.5 Womens Health Key Players Head office and Area Served
3.6 Key Players Womens Health Product Solution and Service
3.7 Date of Enter into Womens Health Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Womens Health Breakdown Data by Type
4.1 Global Womens Health Historic Market Size by Type (2016-2021)
4.2 Global Womens Health Forecasted Market Size by Type (2022-2027)
5 Womens Health Breakdown Data by Application
5.1 Global Womens Health Historic Market Size by Application (2016-2021)
5.2 Global Womens Health Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Womens Health Market Size (2016-2027)
6.2 North America Womens Health Market Size by Type
6.2.1 North America Womens Health Market Size by Type (2016-2021)
6.2.2 North America Womens Health Market Size by Type (2022-2027)
6.2.3 North America Womens Health Market Size by Type (2016-2027)
6.3 North America Womens Health Market Size by Application
6.3.1 North America Womens Health Market Size by Application (2016-2021)
6.3.2 North America Womens Health Market Size by Application (2022-2027)
6.3.3 North America Womens Health Market Size by Application (2016-2027)
6.4 North America Womens Health Market Size by Country
6.4.1 North America Womens Health Market Size by Country (2016-2021)
6.4.2 North America Womens Health Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Womens Health Market Size (2016-2027)
7.2 Europe Womens Health Market Size by Type
7.2.1 Europe Womens Health Market Size by Type (2016-2021)
7.2.2 Europe Womens Health Market Size by Type (2022-2027)
7.2.3 Europe Womens Health Market Size by Type (2016-2027)
7.3 Europe Womens Health Market Size by Application
7.3.1 Europe Womens Health Market Size by Application (2016-2021)
7.3.2 Europe Womens Health Market Size by Application (2022-2027)
7.3.3 Europe Womens Health Market Size by Application (2016-2027)
7.4 Europe Womens Health Market Size by Country
7.4.1 Europe Womens Health Market Size by Country (2016-2021)
7.4.2 Europe Womens Health Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Womens Health Market Size (2016-2027)
8.2 Asia-Pacific Womens Health Market Size by Type
8.2.1 Asia-Pacific Womens Health Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Womens Health Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Womens Health Market Size by Type (2016-2027)
8.3 Asia-Pacific Womens Health Market Size by Application
8.3.1 Asia-Pacific Womens Health Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Womens Health Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Womens Health Market Size by Application (2016-2027)
8.4 Asia-Pacific Womens Health Market Size by Region
8.4.1 Asia-Pacific Womens Health Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Womens Health Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Womens Health Market Size (2016-2027)
9.2 Latin America Womens Health Market Size by Type
9.2.1 Latin America Womens Health Market Size by Type (2016-2021)
9.2.2 Latin America Womens Health Market Size by Type (2022-2027)
9.2.3 Latin America Womens Health Market Size by Type (2016-2027)
9.3 Latin America Womens Health Market Size by Application
9.3.1 Latin America Womens Health Market Size by Application (2016-2021)
9.3.2 Latin America Womens Health Market Size by Application (2022-2027)
9.3.3 Latin America Womens Health Market Size by Application (2016-2027)
9.4 Latin America Womens Health Market Size by Country
9.4.1 Latin America Womens Health Market Size by Country (2016-2021)
9.4.2 Latin America Womens Health Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Womens Health Market Size (2016-2027)
10.2 Middle East & Africa Womens Health Market Size by Type
10.2.1 Middle East & Africa Womens Health Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Womens Health Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Womens Health Market Size by Type (2016-2027)
10.3 Middle East & Africa Womens Health Market Size by Application
10.3.1 Middle East & Africa Womens Health Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Womens Health Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Womens Health Market Size by Application (2016-2027)
10.4 Middle East & Africa Womens Health Market Size by Country
10.4.1 Middle East & Africa Womens Health Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Womens Health Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Womens Health Introduction
11.1.4 Allergan Revenue in Womens Health Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Womens Health Introduction
11.2.4 Bayer Revenue in Womens Health Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Womens Health Introduction
11.3.4 Merck Revenue in Womens Health Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Womens Health Introduction
11.4.4 Pfizer Revenue in Womens Health Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Details
11.5.2 Teva Pharmaceutical Business Overview
11.5.3 Teva Pharmaceutical Womens Health Introduction
11.5.4 Teva Pharmaceutical Revenue in Womens Health Business (2016-2021)
11.5.5 Teva Pharmaceutical Recent Development
11.6 Agile Therapeutics
11.6.1 Agile Therapeutics Company Details
11.6.2 Agile Therapeutics Business Overview
11.6.3 Agile Therapeutics Womens Health Introduction
11.6.4 Agile Therapeutics Revenue in Womens Health Business (2016-2021)
11.6.5 Agile Therapeutics Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Womens Health Introduction
11.7.4 Amgen Revenue in Womens Health Business (2016-2021)
11.7.5 Amgen Recent Development
11.8 Apothecus Pharmaceutical
11.8.1 Apothecus Pharmaceutical Company Details
11.8.2 Apothecus Pharmaceutical Business Overview
11.8.3 Apothecus Pharmaceutical Womens Health Introduction
11.8.4 Apothecus Pharmaceutical Revenue in Womens Health Business (2016-2021)
11.8.5 Apothecus Pharmaceutical Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Womens Health Introduction
11.9.4 AstraZeneca Revenue in Womens Health Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Blairex Laboratories
11.10.1 Blairex Laboratories Company Details
11.10.2 Blairex Laboratories Business Overview
11.10.3 Blairex Laboratories Womens Health Introduction
11.10.4 Blairex Laboratories Revenue in Womens Health Business (2016-2021)
11.10.5 Blairex Laboratories Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Womens Health Introduction
11.11.4 Bristol-Myers Squibb Revenue in Womens Health Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Ferring
11.12.1 Ferring Company Details
11.12.2 Ferring Business Overview
11.12.3 Ferring Womens Health Introduction
11.12.4 Ferring Revenue in Womens Health Business (2016-2021)
11.12.5 Ferring Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Womens Health Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Postmenopausal Osteoporosis
Table 3. Key Players of Endometriosis
Table 4. Key Players of Polycystic Ovary Syndrome
Table 5. Key Players of Infertility
Table 6. Key Players of Menopause
Table 7. Key Players of Others
Table 8. Global Womens Health Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Womens Health Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Womens Health Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Womens Health Market Share by Regions (2016-2021)
Table 12. Global Womens Health Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Womens Health Market Share by Regions (2022-2027)
Table 14. Womens Health Market Trends
Table 15. Womens Health Market Drivers
Table 16. Womens Health Market Challenges
Table 17. Womens Health Market Restraints
Table 18. Global Womens Health Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Womens Health Market Share by Players (2016-2021)
Table 20. Global Top Womens Health Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Womens Health as of 2020)
Table 21. Ranking of Global Top Womens Health Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Womens Health Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Womens Health Product Solution and Service
Table 25. Date of Enter into Womens Health Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Womens Health Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Womens Health Revenue Market Share by Type (2016-2021)
Table 29. Global Womens Health Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Womens Health Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Womens Health Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Womens Health Revenue Market Share by Application (2016-2021)
Table 33. Global Womens Health Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Womens Health Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Womens Health Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Womens Health Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Womens Health Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Womens Health Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Womens Health Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Womens Health Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Womens Health Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Womens Health Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Womens Health Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Womens Health Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Womens Health Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Womens Health Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Womens Health Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Womens Health Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Womens Health Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Womens Health Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Womens Health Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Womens Health Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Womens Health Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Womens Health Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Womens Health Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Womens Health Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Womens Health Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Womens Health Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Womens Health Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Womens Health Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Womens Health Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Womens Health Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Womens Health Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Womens Health Market Size by Country (2022-2027) & (US$ Million)
Table 65. Allergan Company Details
Table 66. Allergan Business Overview
Table 67. Allergan Womens Health Product
Table 68. Allergan Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 69. Allergan Recent Development
Table 70. Bayer Company Details
Table 71. Bayer Business Overview
Table 72. Bayer Womens Health Product
Table 73. Bayer Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 74. Bayer Recent Development
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Womens Health Product
Table 78. Merck Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 79. Merck Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Womens Health Product
Table 83. Pfizer Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Teva Pharmaceutical Company Details
Table 86. Teva Pharmaceutical Business Overview
Table 87. Teva Pharmaceutical Womens Health Product
Table 88. Teva Pharmaceutical Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 89. Teva Pharmaceutical Recent Development
Table 90. Agile Therapeutics Company Details
Table 91. Agile Therapeutics Business Overview
Table 92. Agile Therapeutics Womens Health Product
Table 93. Agile Therapeutics Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 94. Agile Therapeutics Recent Development
Table 95. Amgen Company Details
Table 96. Amgen Business Overview
Table 97. Amgen Womens Health Product
Table 98. Amgen Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 99. Amgen Recent Development
Table 100. Apothecus Pharmaceutical Company Details
Table 101. Apothecus Pharmaceutical Business Overview
Table 102. Apothecus Pharmaceutical Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 103. Apothecus Pharmaceutical Recent Development
Table 104. AstraZeneca Company Details
Table 105. AstraZeneca Business Overview
Table 106. AstraZeneca Womens Health Product
Table 107. AstraZeneca Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 108. AstraZeneca Recent Development
Table 109. Blairex Laboratories Company Details
Table 110. Blairex Laboratories Business Overview
Table 111. Blairex Laboratories Womens Health Product
Table 112. Blairex Laboratories Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 113. Blairex Laboratories Recent Development
Table 114. Bristol-Myers Squibb Company Details
Table 115. Bristol-Myers Squibb Business Overview
Table 116. Bristol-Myers Squibb Womens Health Product
Table 117. Bristol-Myers Squibb Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 118. Bristol-Myers Squibb Recent Development
Table 119. Ferring Company Details
Table 120. Ferring Business Overview
Table 121. Ferring Womens Health Product
Table 122. Ferring Revenue in Womens Health Business (2016-2021) & (US$ Million)
Table 123. Ferring Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Womens Health Market Share by Type: 2020 VS 2027
Figure 2. Postmenopausal Osteoporosis Features
Figure 3. Endometriosis Features
Figure 4. Polycystic Ovary Syndrome Features
Figure 5. Infertility Features
Figure 6. Menopause Features
Figure 7. Others Features
Figure 8. Global Womens Health Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Womens Health Report Years Considered
Figure 13. Global Womens Health Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Womens Health Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Womens Health Market Share by Regions: 2020 VS 2027
Figure 16. Global Womens Health Market Share by Regions (2022-2027)
Figure 17. Global Womens Health Market Share by Players in 2020
Figure 18. Global Top Womens Health Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Womens Health as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Womens Health Revenue in 2020
Figure 20. Global Womens Health Revenue Market Share by Type (2016-2021)
Figure 21. Global Womens Health Revenue Market Share by Type (2022-2027)
Figure 22. North America Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Womens Health Market Share by Type (2016-2027)
Figure 24. North America Womens Health Market Share by Application (2016-2027)
Figure 25. North America Womens Health Market Share by Country (2016-2027)
Figure 26. United States Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Womens Health Market Share by Type (2016-2027)
Figure 30. Europe Womens Health Market Share by Application (2016-2027)
Figure 31. Europe Womens Health Market Share by Country (2016-2027)
Figure 32. Germany Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Womens Health Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Womens Health Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Womens Health Market Share by Region (2016-2027)
Figure 42. China Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Womens Health Market Share by Type (2016-2027)
Figure 50. Latin America Womens Health Market Share by Application (2016-2027)
Figure 51. Latin America Womens Health Market Share by Country (2016-2027)
Figure 52. Mexico Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Womens Health Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Womens Health Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Womens Health Market Share by Country (2016-2027)
Figure 58. Turkey Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Womens Health Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Allergan Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 65. Teva Pharmaceutical Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 66. Agile Therapeutics Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 67. Amgen Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 68. Apothecus Pharmaceutical Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 69. AstraZeneca Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 70. Blairex Laboratories Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 72. Ferring Revenue Growth Rate in Womens Health Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の多嚢胞性卵巣症候群市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Polycystic Ovary Syndrome Market The global Polycystic Ovary Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…- 世界の女性健康療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Women Health Therapeutics Market The global Women Health Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の閉経後骨粗鬆症治療薬市場規模・現状・予測（2021年-2027年） Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone. The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease. Market Analysis a…
- 世界の女性健康管理市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Women Health Care Market The global Women Health Care market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
- 世界の多嚢胞性卵巣症候群治療市場規模・現状・予測（2021年-2027年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…